Diagnostic Imaging Devices - Estonia

The Diagnostic Imaging Devices market market in Estonia is anticipated to witness impressive growth, with projected revenue of US$24.76m in 2024.
This growth is expected to continue at a steady pace, with an annual growth rate (CAGR 2024-2029) of 5.13%.
By 2029, the market volume is estimated to reach US$31.81m.
When compared globally, it is noteworthy that the United States is expected to generate the highest revenue in the Diagnostic Imaging Devices market market, with an estimated revenue of US$11.93bn in 2024.
Estonia's Diagnostic Imaging Devices market is rapidly growing, driven by the country's commitment to advanced healthcare technology and digital innovation.

Definition:
The market covers diagnostic imaging devices such as X-ray systems, ultrasound systems, computed tomography scanners, Magnetic resonance imaging (MRT) systems, and related components.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Siemens Healthineers, General Electric, Philips, Fujifilm Holdings. Further information on the key players can be found in the Market Shares boxes.

X-ray systems
Computed tomography (CT) scanners
Magnetic resonance imaging (MRT) systems
Positron emission tomography (PET) scanners

Non-imaging diagnostics
In vitro diagnostics (IVD)

The Diagnostic Imaging Devices market in Estonia has been experiencing steady growth in recent years.

Customer preferences: Customers in Estonia are increasingly demanding advanced and high-quality diagnostic imaging devices. They value accuracy, speed, and reliability in the diagnosis process, and are willing to invest in state-of-the-art imaging technology. Additionally, there is a growing preference for non-invasive imaging techniques that minimize patient discomfort and reduce the need for invasive procedures.

Trends in the market: One of the key trends in the Diagnostic Imaging Devices market in Estonia is the increasing adoption of digital imaging technology. Digital imaging offers several advantages over traditional film-based imaging, including faster image acquisition, enhanced image quality, and easier storage and sharing of images. This trend is driven by the need for more efficient and streamlined healthcare processes, as well as the growing availability of digital imaging solutions in the market. Another trend in the market is the rising demand for portable and handheld imaging devices. These devices enable healthcare professionals to perform imaging procedures at the point of care, reducing the need for patients to travel to imaging centers or hospitals. This trend is particularly relevant in rural areas where access to healthcare facilities may be limited. Portable imaging devices also offer cost savings and increased convenience for healthcare providers.

Local special circumstances: Estonia has a well-developed healthcare system with a strong focus on preventive care and early diagnosis. The government has implemented various initiatives to promote the use of diagnostic imaging devices in order to improve healthcare outcomes and reduce healthcare costs. This includes investments in infrastructure, training programs for healthcare professionals, and reimbursement policies that encourage the use of advanced imaging techniques.

Underlying macroeconomic factors: Estonia has a stable economy with a high level of digitalization and technological advancement. This provides a favorable environment for the growth of the Diagnostic Imaging Devices market, as healthcare providers have the financial means and technological infrastructure to invest in advanced imaging solutions. Additionally, the aging population in Estonia is driving the demand for diagnostic imaging devices, as older individuals are more likely to require medical imaging for the diagnosis and monitoring of various health conditions. In conclusion, the Diagnostic Imaging Devices market in Estonia is experiencing growth due to customer preferences for advanced and high-quality imaging devices, the adoption of digital imaging technology, and the rising demand for portable and handheld devices. The local special circumstances, including the focus on preventive care and early diagnosis, and the underlying macroeconomic factors, such as the stable economy and aging population, further contribute to the development of the market.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.